Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Esophageal Diseases

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Esophageal Diseases in 1 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Esophageal Diseases: Pathological processes in the ESOPHAGUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yu, HP1
Shi, LY1
Lu, WH1
Su, YH1
Li, YY1
Xu, SQ1

Other Studies

1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Esophageal Diseases

ArticleYear
Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
    Journal of gastroenterology and hepatology, 2004, Volume: 19, Issue:6

    Topics: Apoptosis; Carcinoma, Squamous Cell; Caspase 3; Caspases; Cell Division; Cyclooxygenase 2; Cyclooxyg

2004